Building stem-cell genomics in California and beyond

Nature Biotechnology

Volumn 30, Issue 1, 2012, Pages 20-25

  Dewitt, Natalie D ^a   Yaffe, Michael P ^a   Trounson, Alan ^a  

^a California Institute for Regenerative Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; TRANSCRIPTOME;

COPY NUMBER VARIATION; DNA MODIFICATION; DNA SEQUENCE; EPIGENETICS; FUNDING; GENOMICS; GENOTYPE PHENOTYPE CORRELATION; HLA TYPING; HUMAN; INFORMATION PROCESSING; METHODOLOGY; NOTE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; STANDARD; STEM CELL; TRANSLATIONAL RESEARCH; UNITED STATES;

BIOTECHNOLOGY; CALIFORNIA; DNA COPY NUMBER VARIATIONS; DRUG INDUSTRY; EPIGENOMICS; GENOMICS; HUMANS; STEM CELLS; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84855536381     PISSN: 10870156     EISSN: 15461696     Source Type: Journal    
DOI: 10.1038/nbt.2086     Document Type: Note

References (14)

1. National Research Council of the National Academies. Committee on a Framework for Development a New Taxonomy of Disease; National Research Council. Toward Precision Medicine: Building a Knowledge Network for Biomedical Research and a New Taxonomy of Disease. (The National Academies Press, Washington, DC, 2011).
2. Mayshar, Y. et al. Cell Stem Cell 7, 521-531 (2010).
3. Gore et al. Nature 47, 63-67 (2011).
4. Hussein, S.M. et al. Nature 471, 58-62 (2011).
5. Subkhankulova, T. et al. BMC Genomics 9, 268 (2008).
6. Stahlberg, A. et al. Nucleic Acids Res. 39, e24 (2011).
7. Kalisky, T. & Quake, S. Nat. Methods 8, 311-314 (2011).
8. Eldar, A. & Elowitz, M.B. Nature 467, 167-173 (2010).
9. Reya, T. et al. Nature 414, 105-111 (2001).
10. Bao, S. et al. Nature 444, 756-760 (2006).
11. Dean, M. et al. Nat. Rev. Cancer 5, 275-284 (2005).
12. Bernstein, B.E. et al. Nat. Biotechnol. 28, 1045-1048 (2010).
13. Gerstein, M.B. et al. Genome Res. 17, 669-681 (2007).
14. Lu, R. et al. Nature 462, 358-362 (2009).